EISENBERG JEFFREY F 4
4 · Xenetic Biosciences, Inc. · Filed Oct 30, 2017
Insider Transaction Report
Form 4
EISENBERG JEFFREY F
Director
Transactions
- Award
Common Stock
2017-10-26+50,000→ 50,000 total - Award
Stock Options
2017-10-26+250,000→ 250,000 totalExercise: $2.11Exp: 2027-10-26→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]This represents the grant of a restricted stock unit ("RSU") award. Each RSU represents the right to receive one share of the Issuer's common stock at vesting. The shares underlying the RSUs will vest and become exercisable as follows: one-third on the first anniversary of October 26, 2017 (the "Vesting Start Date"); one-third on the second anniversary of the Vesting Start Date; and one-third on the third anniversary of the Vesting Start Date.
- [F2]The shares underlying the option will vest and become exercisable as follows: 41,666 shares shall vest on the first anniversary of October 26, 2017 (the "Vesting Start Date"); 41,667 shares shall vest on the second anniversary of the Vesting Start Date; 41,667 shares shall vest on the third anniversary of the Vesting Start Date; 100,000 shares shall vest upon the achievement of key clinical milestones for XBIO-101; and 25,000 shares shall vest upon the achievement of key development milestones related to PSA. The Reporting Owner may not exercise any of the shares under the option if and until the Issuer receives shareholder approval of an increase in the number of shares of common stock authorized under the Company's equity incentive plan on or prior to October 11, 2018.